Moonfare’s recent investment strategy opens a door to a key industry nowadays, expected to reach $727bn by 2025 – biotechnology.
The fund manager holds a strong track record of investing in the fastest growing generation of healthcare companies, operating at the intersection of tech and biotech.
To learn more about opportunities to invest in private equity funds, please contact our team or your dedicated relationship manager. Please note that for regulatory reasons, Moonfare is only permitted to share specific investment opportunities with qualified registered users.
